Stock Screener App

Gratuito -

0.6419

4.04% +0.025

Pre-mercato: .6419

Bioline Rx Ltd ADR (BLRX)

Panoramica Notizia Cronologia dei prezzi Catena di opzioni Perché BLRX Giù? Forum Previsione Frazionamento azionario

Bioline Rx Ltd ADR Borsa (BLRX) Ultime notizie

BioLineRx Reveals Cost-Saving Stem Cell Mobilization Data - TipRanks.com - TipRanks

BioLineRx Enhances Multiple Myeloma Treatment - TipRanks.com - TipRanks

What is BLRX's price-to-sales ratio telling us about the company's value? – US Post News - US Post News

BioLineRx secures $6 million through direct offering - Investing.com ZA - Investing.com South Africa

Investing.com South Africa

BioLineRx Announces Major Commercial Milestones - TipRanks.com - TipRanks

BioLineRx begins phase 2 trial for pancreatic cancer treatment - Investing.com South Africa

Investing.com South Africa

HC Wainwright & Co. Maintains Buy Rating for BioLine Rx: Here's What You Need To Know - Markets Insider

Markets Insider

7 High-Potential Penny Stocks in the Biotech Sector - InvestorPlace

The 3 Best Biotech Stocks Under $1 to Buy for April - InvestorPlace

BiolineRx Has Huge Upside In 2018 (NASDAQ:BLRX) - Seeking Alpha

Stock Update (NASDAQ:BLRX): Bioline RX Ltd Sets in Motion Phase 3 Trial for Stem Cell Mobilization Therapy BL-8040 - Yahoo Finance

$76.97

4.27%

$151.22

2.59%

$29.65

1.89%

$171.03

3.73%

$376.60

0.10%

$92.98

0.85%

Apri su Yahoo | Apri su Google | Aperto in Finviz